﻿{"id":1554822,"date":"2020-12-25T00:05:08","date_gmt":"2020-12-24T21:05:08","guid":{"rendered":"http:\/\/www.erzurumflas.com\/bakan-koca-cinden-gelecek-asinin-turk-insaninda-etkili-ve-guvenilir-oldugundan-eminiz\/"},"modified":"2020-12-25T00:05:11","modified_gmt":"2020-12-24T21:05:11","slug":"bakan-koca-cinden-gelecek-asinin-turk-insaninda-etkili-ve-guvenilir-oldugundan-eminiz","status":"publish","type":"post","link":"https:\/\/www.erzhaber.com.tr\/?p=1554822","title":{"rendered":"Bakan Koca: \u201c\u00c7in\u2019den gelecek a\u015f\u0131n\u0131n T\u00fcrk insan\u0131nda etkili ve g\u00fcvenilir oldu\u011fundan eminiz\u201d"},"content":{"rendered":"<p><img decoding=\"async\" src=\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2020\/12\/bakan-koca-cinden-gelecek-asinin-turk-insaninda-etkili-ve-guvenilir-oldugundan-eminiz_2ad2669.jpg\" width=\"600\">Sa\u011fl\u0131k Bakan\u0131 Fahrettin Koca, \u00c7in\u2019den gelecek a\u015f\u0131n\u0131n pazar\u0131 pazartesiye ba\u011flayan gece yola \u00e7\u0131kaca\u011f\u0131n\u0131 belirterek, &#8220;Art\u0131k a\u015f\u0131n\u0131n T\u00fcrk insan\u0131nda etkili ve g\u00fcvenilir oldu\u011fundan eminiz&#8221; dedi.<\/p>\n<p>Sa\u011fl\u0131k Bakan\u0131 Fahrettin Koca, Koronavir\u00fcs Bilim Kurulu toplant\u0131s\u0131 bas\u0131n mensuplar\u0131na a\u00e7\u0131klamalarda bulundu. Korona vir\u00fcsle ilgili verileri payla\u015fan Koca,  \u201cTarih bu y\u0131llar\u0131 hastal\u0131\u011fa ad\u0131n\u0131 veren 2019\u2019dan ba\u015flayarak, b\u00fcy\u00fck salg\u0131n y\u0131llar\u0131 olarak anacakt\u0131r. Bug\u00fcne kadar Almanya\u2019da her 1 milyon n\u00fcfus ba\u015f\u0131na 325 ki\u015fi bu hastal\u0131k nedeniyle hayat\u0131n\u0131 kaybetti. S\u00fcr\u00fc ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n\u0131 uygulamaya \u00e7al\u0131\u015fan \u0130sve\u00e7\u2019te 789, en \u00e7ok vaka ve vefat say\u0131s\u0131na ula\u015fan ABD\u2019de 984, vir\u00fcste mutasyon g\u00f6r\u00fcld\u00fc\u011f\u00fc iddias\u0131yla g\u00fcndeme gelen \u0130ngiltere\u2019de 994 ki\u015fi \u00f6ld\u00fc. T\u00fcrkiye\u2019de ise milyon n\u00fcfus ba\u015f\u0131na vefat say\u0131m\u0131z 216\u2019ya ula\u015ft\u0131. G\u00fcnl\u00fck vaka say\u0131lar\u0131 d\u00fcnyada nisan ay\u0131ndaki ilk pik d\u00f6neminde 80 binlerdeydi. \u015eu an ise neredeyse 9 kat art\u0131\u015fla 700 binlere ula\u015ft\u0131. Bununla birlikte nisan ortas\u0131ndaki ilk pik d\u00f6neminde 8 bin 500 civar\u0131ndaki g\u00fcnl\u00fck vefat say\u0131lar\u0131n\u0131n \u015fu an y\u00fczde 70 art\u0131\u015fla 14 binlere ula\u015ft\u0131\u011f\u0131n\u0131 \u00fcz\u00fcnt\u00fcyle g\u00f6r\u00fcyoruz\u201d diye konu\u015ftu.<\/p>\n<p>\u201c\u0130stanbul\u2019da vaka say\u0131lar\u0131nda \u00f6nemli d\u00fc\u015f\u00fc\u015f sa\u011fland\u0131\u201d<\/p>\n<p>T\u00fcrkiye\u2019nin ekim ay\u0131n\u0131n ikinci yar\u0131s\u0131ndan itibaren h\u0131zl\u0131 bir vaka art\u0131\u015f\u0131 g\u00f6sterdi\u011fi bilgisini veren Bakan Koca, \u201cBir\u00e7ok ilimizde y\u00fczde 100\u2019leri a\u015fan art\u0131\u015flar oldu. Hastanelerimiz, yo\u011fun bak\u0131mlar\u0131m\u0131z y\u00fck\u00fc kald\u0131rmada zorlanmaya ba\u015flad\u0131. \u0130l ziyaretleri ile yerinde de\u011ferlendirme, HES kodunun t\u00fcm kamu kurumlar\u0131nda, ula\u015f\u0131mda ve konaklama tesislerinde kullan\u0131m\u0131n\u0131n yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131, toplu etkinliklerin ertelenmesi, d\u00fc\u011f\u00fcn, ni\u015fan gibi t\u00f6renlere k\u0131s\u0131tlama getirilmesi, kademeli mesai uygulamas\u0131 \u00e7e\u015fitli i\u015f yerlerinin \u00e7al\u0131\u015fma saatleri ve hizmet sunum \u015feklinin s\u0131n\u0131rland\u0131r\u0131lmas\u0131, kalabal\u0131k meydan ve sokaklar i\u00e7in getirilen k\u0131s\u0131tlama ve kontroller, a\u00e7\u0131kta sigara i\u00e7me yasa\u011f\u0131, okullar\u0131n tekrar uzaktan e\u011fitime ge\u00e7mesi, hafta i\u00e7i geceleri ve hafta sonu d\u0131\u015far\u0131 \u00e7\u0131kma yasa\u011f\u0131 gibi yayg\u0131n tedbirler hayata ge\u00e7irildi.  S\u0131k\u0131 tedbirlerin uygulanmas\u0131 sayesinde g\u00fcnl\u00fck vaka say\u0131m\u0131zda Gaziantep\u2019te y\u00fczde 66, Tekirda\u011f, Bursa ve \u0130zmir\u2019de y\u00fczde 60, Ankara ve Samsun\u2019da y\u00fczde 55, Trabzon ve Adana\u2019da y\u00fczde 50, Diyarbak\u0131r ve Hatay\u2019da y\u00fczde 48, Kayseri ve Kocaeli\u2019nde y\u00fczde 45, \u015eanl\u0131urfa\u2019da y\u00fczde 40, Antalya\u2019da y\u00fczde 30 ve Mersin\u2019de y\u00fczde 30\u2019a varan d\u00fc\u015f\u00fc\u015fler sa\u011fland\u0131. \u0130stanbul\u2019da vaka say\u0131lar\u0131nda \u00f6nemli d\u00fc\u015f\u00fc\u015f sa\u011flan\u0131rken, poliklinik ba\u015fvurular\u0131nda y\u00fczde 50, hastane yat\u0131\u015flar\u0131na ve yo\u011fun bak\u0131m doluluk oranlar\u0131na ise y\u00fczde 25 olarak yans\u0131d\u0131\u201d \u015feklinde konu\u015ftu.<\/p>\n<p>&#8220;T\u00fcrkiye salg\u0131n\u0131n ba\u015f\u0131ndan beri tedbirleri en erken alan \u00fclkelerin ba\u015f\u0131nda gelmektedir&#8221;<\/p>\n<p>\u0130ngiltere\u2019nin vir\u00fcs\u00fcn mutasyonuyla ilgili a\u00e7\u0131klamada bulundu\u011funu kaydeden Sa\u011fl\u0131k Bakan\u0131 Koca, \u015fu ifadelere yer verdi:<\/p>\n<p>\u201cBilinmelidir ki bu mutasyon eyl\u00fcl ay\u0131ndan beridir mevcut. Korona vir\u00fcs zaten damlac\u0131k enfeksiyonu ile bula\u015fan bir hastal\u0131kt\u0131r ve yay\u0131lma h\u0131z\u0131 \u00e7ok y\u00fcksektir. Mutasyonun yay\u0131lma h\u0131z\u0131n\u0131 artt\u0131rmas\u0131 \u00e7arpan etkisi yapabilir. Ancak mutasyon ve varyasyonlar, d\u00fczenli olarak taranmaktad\u0131r. \u00dclkemizde Halk Sa\u011fl\u0131\u011f\u0131 Laboratuvarlar\u0131m\u0131z bu i\u015fi d\u00fczenli olarak yapmakta ve geli\u015fmeleri D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc\u2019ne bildirmektedir. Anla\u015f\u0131lan o ki \u0130ngiltere\u2019deki kontrols\u00fcz vaka art\u0131\u015f\u0131n\u0131n nedeni ara\u015ft\u0131r\u0131l\u0131rken, eyl\u00fcl ay\u0131ndan beri var olan mutasyon ilgililerin dikkatini \u00e7ekmi\u015ftir. T\u00fcrkiye salg\u0131n\u0131n ba\u015f\u0131ndan beri t\u00fcm geli\u015fmeleri dikkate alarak hastal\u0131\u011f\u0131 \u00f6nemseyerek tedbirleri en erken alan \u00fclkelerin ba\u015f\u0131nda gelmektedir. Bu sayede vir\u00fcs\u00fcn T\u00fcrkiye\u2019ye giri\u015fini 3 ay geciktirdik. Mutasyonlar konusunda da d\u00fczenli incelemelerimiz hep devam etti. Vir\u00fcs daha h\u0131zl\u0131 bula\u015fsa da tedbirler yine en etkili silah\u0131m\u0131z. Ayr\u0131ca DS\u00d6 de bu durumun a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131n\u0131 olumsuz etkilemeyece\u011fini a\u00e7\u0131klad\u0131.\u201d<\/p>\n<p>\u201c\u0130naktif a\u015f\u0131n\u0131n \u00fclkemizdeki Faz-3 klinik \u00e7al\u0131\u015fmas\u0131 ba\u015far\u0131yla s\u00fcrmektedir\u201d<\/p>\n<p>T\u00fcrkiye\u2019de adenovir\u00fcs temelli iki a\u015f\u0131 aday\u0131n\u0131n insan deneyleri safhas\u0131na ula\u015ft\u0131\u011f\u0131n\u0131n bilgisini veren Koca, \u201cBenzer \u015fekilde vir\u00fcs benzeri par\u00e7ac\u0131klar temelli bir a\u015f\u0131m\u0131z da insan deneyleri safhas\u0131ndad\u0131r. En \u00e7ok merak edilen konulardan biri de a\u015f\u0131n\u0131n ne zaman gelece\u011fi zannediyorum. Ba\u015f\u0131ndan beri T\u00fcrkiye\u2019de klinik \u00e7al\u0131\u015fmas\u0131 olan kendi in\u015fam\u0131zda etkisi oldu\u011funu bildi\u011fimiz bir a\u015f\u0131y\u0131 kullanmak istedi\u011fimizi beyan ettik. Tercih etti\u011fimiz a\u015f\u0131n\u0131n da klinik deneylerini bekleyip ona g\u00f6re harekete ge\u00e7mek i\u00e7in u\u011fra\u015f verdik. \u0130naktif a\u015f\u0131n\u0131n \u00fclkemizdeki Faz-3 klinik \u00e7al\u0131\u015fmas\u0131 ba\u015far\u0131yla s\u00fcrmektedir. Vaka say\u0131lar\u0131n\u0131n y\u00fcksek oldu\u011fu g\u00fcnlerde \u00e7al\u0131\u015fmada \u00e7ok h\u0131zla ilerlemekteydi. A\u015f\u0131lanan g\u00f6n\u00fcll\u00fclerin ister ger\u00e7ek a\u015f\u0131yla, ister plasebo a\u015f\u0131yla a\u015f\u0131lans\u0131n hastal\u0131\u011fa yakalan\u0131p yakalanmayaca\u011f\u0131 izlenmektedir. Bu durumda \u00fclkede \u00e7ok vaka varken \u00e7al\u0131\u015fma daha h\u0131zl\u0131 ilerlemektedir\u201d dedi.<\/p>\n<p>&#8220;A\u015f\u0131lar\u0131m\u0131z bir aksilik olmazsa, pazar\u0131 pazartesiye ba\u011flayan gece yola \u00e7\u0131k\u0131yor&#8221;<\/p>\n<p>A\u015f\u0131n\u0131n T\u00fcrkiye\u2019ye Pazar\u2019\u0131 pazartesiye ba\u011fland\u0131\u011f\u0131 gece yola \u00e7\u0131kaca\u011f\u0131n\u0131n m\u00fcjdesini veren Koca, \u201cBilim Kurulu\u2019nun de\u011ferlendirmeleriyle a\u015f\u0131n\u0131n \u00fclkemizde kullan\u0131lmas\u0131 konusunda kendi insan\u0131m\u0131zda g\u00f6sterdi\u011fi etkiden emin olduk. Art\u0131k a\u015f\u0131n\u0131n T\u00fcrk insan\u0131nda etkili ve g\u00fcvenilir oldu\u011funda eminiz. \u00c7in makamlar\u0131 da T\u00fcrkiye\u2019ye g\u00f6nderilecek a\u015f\u0131 dozlar\u0131 i\u00e7in onay i\u015flemlerini tamamlad\u0131. \u00dcreticinin depolar\u0131nda haz\u0131r olarak bizden gelecek haberleri bekleyen a\u015f\u0131lar\u0131m\u0131z bir aksilik olmazsa, pazar\u0131 pazartesiye ba\u011flayan gece yola \u00e7\u0131k\u0131yor\u201d a\u00e7\u0131klamas\u0131nda bulundu.<\/p>\n<p>&#8220;En s\u0131k g\u00f6r\u00fclen yan etkiler yorgunluk y\u00fczde 4,7, ba\u015f a\u011fr\u0131s\u0131 y\u00fczde 3,9 ve a\u015f\u0131n\u0131n yap\u0131ld\u0131\u011f\u0131 b\u00f6lgede a\u011fr\u0131 y\u00fczde 1,9&#8221;<\/p>\n<p>A\u015f\u0131 hakk\u0131nda bilgi veren Prof. Dr. Serhat \u00dcnal ise, \u201c\u00c7in Sinovac taraf\u0131ndan \u00fcretilen inaktif a\u015f\u0131, \u00e7al\u0131\u015fmalar\u0131 14 Eyl\u00fcl\u2019de \u00fclkemizde ba\u015flat\u0131ld\u0131. D\u00fcn yap\u0131lan de\u011ferlendirilmeye g\u00f6re 23 Aral\u0131k 2020 itibariyle 24 merkezde 9 bin 150 g\u00f6n\u00fcll\u00fc taranm\u0131\u015f, bunlardan 7 bin 371\u2019i g\u00f6n\u00fcll\u00fc \u00e7al\u0131\u015fmaya al\u0131nm\u0131\u015ft\u0131r. 4 bin 759 g\u00f6n\u00fcll\u00fc a\u015f\u0131 kolunda y\u00fczde 64\u2019\u00fcn\u00fc yap\u0131yor, 2 bin 612\u2019si de plasebo kolunda y\u00fczde 35\u2019ini yap\u0131yor. Bine yak\u0131n say\u0131da sa\u011fl\u0131k personeli bire bir randomize edilmek \u00fczere \u00e7al\u0131\u015f\u0131ld\u0131. 18 Kas\u0131m\u2019dan itibaren de sa\u011fl\u0131k personelinden ba\u015flamam\u0131z\u0131n nedeni g\u00fcvenlik datas\u0131n\u0131 iyi takip edebilmekti. \u0130lk 900\u2019dan fazla \u00e7al\u0131\u015fmaya al\u0131nan ki\u015finin g\u00fcvenlik datas\u0131 incelenip g\u00fcvenli\u011fine karar verildikten sonra ikinci k\u0131s\u0131mda vatanda\u015flar\u0131m\u0131za yapmaya ba\u015flad\u0131k. O da 18 Kas\u0131m tarihidir. Birincisinde bir a\u015f\u0131 bir plasebo yap\u0131l\u0131rken, ikincisinde a\u015f\u0131ya ula\u015f\u0131m\u0131 artt\u0131rmak amac\u0131yla iki a\u015f\u0131 bir plasebo \u015feklinde yap\u0131ld\u0131. O nedenle iki kolda y\u00fczde 64, y\u00fczde 35 \u015feklinde bir fark var. Tamam\u0131 de\u011ferlendirildi\u011finde bu \u00e7al\u0131\u015fma kapsam\u0131nda 7 bin 371 g\u00f6n\u00fcll\u00fcye 10 bin 828 doz \u015fu anda uygulanm\u0131\u015f durumda. 752 a\u015f\u0131 yap\u0131lm\u0131\u015f ki\u015fide sadece 3 hastal\u0131k olu\u015furken, 570 plasebo yap\u0131lm\u0131\u015f kolda 26 hastal\u0131k meydana geldi. Bunun \u00f6zel istatistiki y\u00f6ntemlerle hesaplanmas\u0131 var. DS\u00d6 g\u00fcven aral\u0131\u011f\u0131 diye g\u00f6rd\u00fc\u011f\u00fcn\u00fcz, y\u00fczde 95 g\u00fcven aral\u0131\u011f\u0131 bu t\u00fcr \u00e7al\u0131\u015fmalarda kullan\u0131lan standart bir y\u00f6ntemdir. Alt s\u0131n\u0131r\u0131 y\u00fczde 71 \u00fcst s\u0131n\u0131r\u0131 y\u00fczde 97 olmak \u00fczere, yani bu \u00e7al\u0131\u015fmay\u0131 y\u00fczlerce binlerce kez tekrar etseniz, en k\u00f6t\u00fc ihtimalle y\u00fczde 71 etkinlik ki DS\u00d6 bunun y\u00fczde 50 olmas\u0131n\u0131 yeterli g\u00f6r\u00fcyor. \u00dcst s\u0131n\u0131rda da en iyi ihtimalle y\u00fczde 97 oranla ba\u015far\u0131l\u0131 bulaca\u011f\u0131n\u0131 g\u00f6steriyor. Bu g\u00fcvenlik aral\u0131\u011f\u0131 i\u00e7inde toplam a\u015f\u0131 etkinli\u011fi y\u00fczde 91,25 olarak hesaplanm\u0131\u015ft\u0131r. \u00d6n\u00fcm\u00fczdeki g\u00fcnlerde daha da artacakt\u0131r.<\/p>\n<p>\u0130kinci de\u011ferlendirdi\u011fimiz a\u015f\u0131 g\u00fcvenilirli\u011fi analizleri 2 bin 964 ki\u015fi verisiyle yap\u0131ld\u0131. En s\u0131k g\u00f6r\u00fclen yan etkiler yorgunluk y\u00fczde 4,7, ba\u015f a\u011fr\u0131s\u0131 y\u00fczde 3,9 ve a\u015f\u0131n\u0131n yap\u0131ld\u0131\u011f\u0131 b\u00f6lgede a\u011fr\u0131 y\u00fczde 1,9. \u0130kinci a\u015f\u0131da bunlar biraz daha \u015fiddetlenebilir. \u0130kinci a\u015f\u0131da ayn\u0131 etkiler yorgunluk y\u00fczde 2,5, ba\u015f a\u011fr\u0131s\u0131 2,3 \u00e7ok daha d\u00fc\u015f\u00fck ki iki bulgu da plasebo kolunda da g\u00f6zlenen, deneklerin hissetti\u011fi duygular ve lokal a\u015f\u0131 b\u00f6lgesinde a\u011fr\u0131 da y\u00fczde 0,5 olarak tespit edilmi\u015ftir. A\u015f\u0131la ilgili bir tana ciddi diyebilece\u011fimiz yan etki, bir arkada\u015f\u0131m\u0131zda hafif alerjik reaksiyon meydana geldi. O da an\u0131nda tedavi edildi. G\u00fcvenlik datas\u0131 a\u00e7\u0131s\u0131ndan g\u00fcvenli g\u00f6r\u00fcn\u00fcyor a\u015f\u0131m\u0131z ve etkinlik a\u00e7\u0131s\u0131ndan da y\u00fczde 91,2.\u201d<\/p>\n<p>\u201cA\u015f\u0131n\u0131n koruyuculu\u011fu y\u00fczde 91.25\u201d<\/p>\n<p>A\u015f\u0131n\u0131n koruyuculu\u011fu y\u00fczde 91.25 oldu\u011funu belirten Koca \u015fu ifadelere yer verdi:<\/p>\n<p>\u201cBu sonu\u00e7lar bu a\u015f\u0131yla ilgili d\u00fcnya a\u00e7\u0131klanan ilk veriler. Dolay\u0131s\u0131yla d\u00fcnya hatta \u00c7in muhtemelen devlet olarak bu datalar\u0131m\u0131z\u0131 kullanacak. A\u015f\u0131n\u0131n koruyuculu\u011fu y\u00fczde 91,25 oran\u0131nda. Bu erken d\u00f6nem ve bu giderek artacak. \u00c7\u00fcnk\u00fc biz normalde 40 enfekte olan ki\u015fi oldu\u011funda a\u00e7\u0131klamay\u0131 d\u00fc\u015f\u00fcnd\u00fc\u011f\u00fcm\u00fcz bir durumdu. \u015eu an 29 ki\u015fi s\u00f6z konusu, o nedenle 40 ki\u015fi enfekte oldu\u011fu d\u00f6neme kadar bu \u00e7al\u0131\u015fma devam ediyor olacak. Ve giderek bu oran\u0131n daha da yukar\u0131 do\u011fru \u00e7\u0131kaca\u011f\u0131n\u0131 s\u00f6yleyebiliriz. A\u015f\u0131 yap\u0131lan b\u00fct\u00fcn g\u00f6n\u00fcll\u00fcler, kimisine plaseba, kimisine a\u015f\u0131 yap\u0131lm\u0131\u015f oldu. Yap\u0131lan ki\u015filerde 29 ki\u015fide enfeksiyon g\u00f6r\u00fclm\u00fc\u015f oldu. 29 ki\u015finin 26\u2019s\u0131 a\u015f\u0131 yap\u0131lmayand\u0131. 3 ki\u015fi a\u015f\u0131 yap\u0131land\u0131. Bu 3 ki\u015fi de sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131yd\u0131. Yani riskli gruptu. D\u00fcnyada riskli gurubu bu \u00e7al\u0131\u015fmalar\u0131n i\u00e7ine alan di\u011fer a\u015f\u0131lar\u0131n da olmad\u0131\u011f\u0131n\u0131 bilelim. Bu riskli olmas\u0131na ra\u011fmen 3 ki\u015finin PCR\u2019si pozitif, ate\u015f ve solunum problemi, akci\u011fer tutumumu olmayan \u00e7ok hafif ge\u00e7iren bir tablo oldu\u011funu biliyoruz. \u00d6zetle o 3 ki\u015finin \u00e7ok hafif ge\u00e7irdi\u011fini rahatl\u0131kla s\u00f6yleyebiliriz.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SA\u011eLIK BAKANI FAHRETT\u0130N KOCA, \u00c7\u0130N&#8217;DEN GELECEK A\u015eININ PAZARI PAZARTES\u0130YE BA\u011eLAYAN GECE YOLA \u00c7IKACA\u011eINI BEL\u0130RTEREK, &#8220;ARTIK A\u015eININ T\u00dcRK \u0130NSANINDA ETK\u0130L\u0130 VE G\u00dcVEN\u0130L\u0130R OLDU\u011eUNDAN EM\u0130N\u0130Z&#8221; DED\u0130.<\/p>\n","protected":false},"author":1,"featured_media":1554823,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[51140,1755,37201,55889,14818,13494,41684,119319,877,28025,1039],"class_list":["post-1554822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","category-turkiye","tag-asinin","tag-bakan","tag-cinden","tag-eminiz","tag-etkili","tag-gelecek","tag-guvenilir","tag-insaninda","tag-koca","tag-oldugundan","tag-turk"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1554822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1554822"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1554822\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/1554823"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1554822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1554822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1554822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}